Manufacturing biologics, including biosimilars, requires highly specialized knowledge of:
We have been building this knowledge for four decades. We are proud of our proven record of delivering quality, reliably supplied biologic medicines. This wouldn’t be possible without a global infrastructure supporting state-of-the-art manufacturing standards.
Each biologic medicine requires its own high-standard operating procedure, something we’re continually investing in and refining. Once that’s in place, we check and recheck to make certain that we can continue to deliver quality biologic medicines.1
Not only that, but we’ve also invested $1 billion to promote supply stability, earning us a reputation for trustworthiness, reliability, and determination to get medication to every patient, every time.